Basic Information
ID: ALA4372641
Type: Binding
Description: Inhibition of USP9x in human K562 cells assessed as decrease in Bcr-Abl expression at 50 uM measured after 4 hrs in presence of proteasome inhibitor bortezomib by Western blot analysis
Format: BAO_0000219
Organism: Homo sapiens
Cell type: K562
Target: Probable ubiquitin carboxyl-terminal hydrolase FAF-X(ALA2406899)
Document: ALA4371052
Inhibition of USP9x in human K562 cells assessed as decrease in Bcr-Abl expression at 50 uM measured after 4 hrs in presence of proteasome inhibitor bortezomib by Western blot analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4372641
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 293.32 | 3.88 | 3.88 |